Please try another search
Wall Street expects a year-over-year decline in earnings on higher revenues when PHASEBIO PHARMA (PHAS) reports results for the quarter ended December 2019. While this widely-known consensus outlook...
Wall Street expects a year-over-year increase in earnings on higher revenues when Neogen (NEOG) reports results for the quarter ended February 2020. While this widely-known consensus outlook is...
The market expects Alector (ALEC) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook...
Wall Street expects a year-over-year increase in earnings on higher revenues when Tsakos Energy (TNP) reports results for the quarter ended December 2019. While this widely-known consensus outlook is...
Wall Street expects a year-over-year decline in earnings on lower revenues when ProPetro Holding (PUMP) reports results for the quarter ended December 2019. While this widely-known consensus outlook...
Wall Street expects a year-over-year decline in earnings on higher revenues when Nike (NYSE:NKE) reports results for the quarter ended February 2020. While this widely-known consensus outlook is...
Pioneer Natural Resources Company (NYSE:PXD) recently announced its plan to reduce 45% of its capex guidance for 2020 drilling, completion and facilities to the tune of $1.6-$1.8 billion, from its...
JOYY Inc. (NASDAQ:YY) reported fourth-quarter 2019 non-GAAP earnings of 96 cents per American depositary shares (ADS) that beat the Zacks Consensus Estimate by 18.5%.Moreover, revenues of $1.09...
A10 Networks (ATEN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of...
Ascendis Pharma A/S (ASND) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one...
Century Communities (CCS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings...
Alector (ALEC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most...
Acorda Therapeutics (ACOR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of...
In the past week, Latin American carrier Azul (NYSE:AZUL) announced fourth-quarter 2019 results wherein it reported better-than-expected earnings per share as well as revenues. Moreover, both...
EOG Resources, Inc. (NYSE:EOG) recently announced its plan to reduce capital expenditure for 2020 by 31% to $4.3-$4.7 billion due to the ongoing turmoil in the hydrocarbon market, which slashed oil...